The alteration of an endorepellin fragment in RCMD, whether it is due to a plasma level increase or posttranslational modification, may be connected to its anti-tumor and anti-angiogenic properties. This evidence concerns the gene HSPG2 and myelodysplastic syndrome with multilineage dysplasia.